Chapter 24: Karen's Lab and the Serum Question
The challenge of being in a room with someone who asks good questions is that you eventually run out of deflections.
Whistler's safe house lab was cramped but functional — the same fortified workshop where I'd delivered the blood rave intelligence briefing, now converted to shared research space. Karen had claimed the primary workstation. I'd set up my portable synthesis equipment on a secondary table near the weapons maintenance area. Whistler moved between his own projects and ours, bringing tools when needed and saying nothing when not needed.
Two days since the hospital. The ritual was approximately ten hours away. Neither of us mentioned it.
Karen walked me through her research status as professional courtesy. "Garlic-derived compound," she said, pulling up her molecular analysis on the terminal. "The anticoagulant mechanism targets vampire cellular membrane stability specifically. It disrupts the retroviral integration at the binding-site level."
I looked at her data. The biochemical pathway was elegant — she'd identified the same vulnerability I'd seen in my Film 1 memory, but she'd arrived at it through genuine research rather than future knowledge.
"Delivery optimization is the remaining challenge," she continued. "The compound is effective but unstable in aerosol form. I need a carrier that maintains potency without degrading the active mechanism."
"Give her something useful. Something she would find independently within two weeks."
"CDC bioweapon protocols include stabilization methodology for unstable aerosol compounds," I said. "The carrier matrix uses lipid encapsulation to protect the active ingredient during dispersal."
Karen made a note. "Lipid encapsulation. That could work for the initial delivery, but the release timing—"
"What triggers the release?"
She paused. Looked at me. "Temperature differential. The membrane breaks down when it contacts the target's body heat."
"Which is lower for vampires than humans."
The pause extended. Karen's expression shifted as she processed the implication.
"The temperature differential is narrower," she said slowly. "Which means the release timing would be slower for vampire targets than human collateral..."
"Making the weapon safer for humans in the dispersal zone."
She wrote something in her research notebook. Then looked at me again. "You framed that as a question."
"It seemed like you were close to the insight."
"I was." Her voice was neutral. Not accusatory, but aware. "You could have just told me."
"You would have learned it anyway."
"In about a week."
"Exactly."
Karen didn't push further. She returned to her molecular analysis and began incorporating the lipid encapsulation methodology into her delivery optimization design.
I returned to my synthesis work and tried to ignore the awareness that she'd identified the information asymmetry management in real time.
Twenty minutes later, Karen noticed something on my workstation.
I was running the Tier 3 synthesis protocol on portable equipment — reduced capacity compared to my lab setup, but functional for maintaining the compound integration during operational pauses. The Cassius elder material was sealed in a temperature-controlled container, but the synthesis process required periodic medium refresh that left trace residue on the surrounding equipment.
Karen picked up a calibration tool I'd been using. Turned it over. Examined a minor smear of dried biological medium on the handle.
Before I could react, she'd scraped a sample into Whistler's field analysis kit.
The results came back in under a minute.
[Sample Analysis: Unknown Third-State Compound. Classification: NOT VAMPIRE. NOT HUMAN. ANOMALOUS.]
Karen looked at me.
I looked at Karen.
"You're not going to explain this," she said.
"Not today."
"Is it dangerous?"
The question was practical. Direct. The same approach she brought to every research problem.
"Not to you."
She held my gaze for several seconds. Processing the answer. Deciding what to do with it.
Then she set down the calibration tool and returned to her workstation.
From across the room, Whistler didn't visibly react. But I read the micro-change in his blood-sigil: the specific pattern of satisfaction. He was pleased about something.
"He expected more friction. He expected her to push harder or me to deflect worse."
I filed the observation and resumed the synthesis protocol.
The next three hours had a quality I didn't have an operational category for.
We worked in parallel. Karen on the anticoagulant delivery optimization, making steady progress on the lipid encapsulation methodology. Me on the Tier 3 synthesis, monitoring the Cassius compound integration and adjusting the cultivation parameters as needed. The portable equipment wasn't ideal, but the synthesis was progressing.
[Tier 3 Synthesis: Day 8/14. Compound Integration: STABLE]
The silence between us wasn't uncomfortable. It was the specific quality of two people who had decided to trust the working relationship before trusting the explanations.
Whistler brought food at some point — sandwiches and coffee, set on a side table without comment. He'd been watching us work, occasionally checking his own projects, maintaining the weapons and equipment that would be needed for whatever happened next. The safe house functioned as an operational hub: research, preparation, staging.
The ritual was nine hours away. The temple location was confirmed. Blade was preparing his approach. And two researchers who knew different pieces of the same puzzle were building weapons in parallel.
At the end of the third hour, Karen asked one more question.
"Is what you're working on going to help us against Frost?"
I set down the synthesis monitor and considered the answer. The Tier 3 ascension wouldn't be complete before the ritual. The Disruption Serum concept was viable but not yet implemented. What I was building now was foundation work for capabilities that might take weeks to fully realize.
"It's going to make what you're building more effective," I said. "And last longer than Frost."
Karen sat with that for a moment. The implication that the current crisis was the beginning of something rather than the end. That whatever happened at the temple tonight, the war wouldn't be over.
She nodded once and returned to her research.
I walked home through the city with the synthesis materials secured in my field kit and the portable equipment running on battery backup.
The safe house lab session had been productive. Karen's anticoagulant delivery optimization was now approximately three days ahead of where it would have been without my input. My synthesis had progressed through another day of integration without the precision equipment I would have preferred.
And three hours of parallel work with Karen Jenson was the closest thing to companionable silence I'd experienced since transmigration.
"No operational category for that."
The observation was accurate. My framework for human interaction since arriving in Cole Drake's body had been transactional: information exchange, capability assessment, relationship management. The lab session had felt different. Not because the work was different — research methodology was familiar territory — but because the silence had been comfortable rather than strategic.
I'd noticed the same quality in my first conversations with Whistler. The gruff honesty that didn't require explanation or justification. The working relationship that existed on its own terms.
"Build something real before the foreknowledge runs out. That's what Whistler said."
The synthesis was running. The anticoagulant was taking shape. The ritual was fifteen hours closer than it had been this morning.
Neither of us had said it. Neither of us had needed to.
Get Early Access to New Chapters
Thank you for reading. For those who want to skip the wait, my Patreon offers early access with 7 new chapters every 10 days.
Scout Tier [$5]: +7 Chapters ahead of public sites.
Vanguard Tier [$9]: +14 Chapters ahead of public sites.
World-Eater Tier [$14]: +21 Chapters ahead of public sites.
Support the project and start reading the next arc now: Patreon.com/IsekaiStories